Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

NCT00383734 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-Associated Lipodystrophy Syndrome

Interventions

DEVICE: Newfill
DEVICE: Eutrophill

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]
[object Object]